Investing Ideas
/
Japanese Pharmaceuticals & Biotech Your first investment

Japanese Pharmaceuticals & Biotech Your first investment

Results

0 new

Based on available information up to March 12, 2025, Donald Trump’s plans for oil and gas focus on maximizing U.S. production, reducing regulatory barriers, and prioritizing fossil fuels as a cornerstone of his energy policy. Here’s a concise overview of his intentions: Boost Production and Permitting: Trump has pledged to "unleash" American oil and gas by accelerating permitting processes. On his first day in office (January 20, 2025), he signed executive orders declaring a "national energy emergency" to fast-track approvals for energy infrastructure like pipelines, refineries, and power plants. This includes expanding drilling on federal lands and offshore areas, reversing Biden-era restrictions.

9 companies

Chugai Pharmaceutical

Market Cap: JP¥11.9t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

4519

JP¥7,212.00

-0.4%

Otsuka Holdings

Market Cap: JP¥5.7t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

4578

JP¥10,915.00

-1.0%

57.6%

Astellas Pharma

Market Cap: JP¥3.9t

Engages in the research, development, manufacture, sale, and supply of pharmaceuticals in Japan and internationally.

4503

JP¥2,161.00

0.6%

45.1%

Shionogi

Market Cap: JP¥2.4t

Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.

4507

JP¥2,848.00

0.2%

12.0%

Kyowa Kirin

Market Cap: JP¥1.4t

Engages in the research, development, manufacturing, and marketing of pharmaceuticals in Japan, the Americas, Europe, Asia, and internationally.

4151

JP¥2,594.00

-1.9%

0.8%

Ono Pharmaceutical

Market Cap: JP¥1.1t

Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.

4528

JP¥2,398.50

2.2%

46.6%

Santen Pharmaceutical

Market Cap: JP¥631.3b

Engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.

4536

JP¥1,962.50

-6.2%

16.8%

Tsumura

Market Cap: JP¥284.9b

Engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally.

4540

JP¥3,822.00

-1.0%

4.3%

Nippon Shinyaku

Market Cap: JP¥270.7b

Manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally.

4516

JP¥4,017.00

0.7%

24.3%